The DRx Capital-backed healthcare database developer scored fresh capital to increase its overall funding to over $190m.

H1, a US-based healthcare data software provider backed by pharmaceutical firm Novartis and mobile chipmaker Qualcomm, secured $100m in series C funding on Tuesday.

Technology investment firm Altimeter Capital led the round and was joined by investment bank Goldman Sachs’ Asset Management business, IVP, Menlo Ventures, Lux Capital, Lead Edge Capital and Transformation Capital.

Founded in 2017, H1 operates a cloud-based database designed to help hospitals, life science companies, health systems and academic centres gain medical insights. The series C…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
Email LinkedIn